Clinical reference Biomarker Directory
Back to directory

Amylase

Established

Amylase is a pancreatic/salivary enzyme historically used to diagnose pancreatitis, now superseded by lipase.

Also known as Serum amylase pancreatic amylase (isoenzyme)
In plain language

Amylase is a digestive enzyme once used to diagnose pancreatitis, but doctors now prefer a different enzyme, lipase, because it's more accurate. Ordering both tests together doesn't help and just adds cost.

Biomarker & context

Amylase is a digestive enzyme produced by the pancreas and salivary glands that breaks down starches. Serum elevation has traditionally been used to help diagnose acute pancreatitis.

What it indicates

Elevated serum amylase suggests pancreatic injury (acute pancreatitis) but is nonspecific — it also rises in salivary gland disease, bowel obstruction, and other abdominal conditions, and up to 60% of circulating amylase can originate from non-pancreatic sources.

Diagnosis & clinical testing

Current guidelines (ACG, Japanese pancreatitis guidelines) now explicitly recommend against measuring amylase for acute pancreatitis diagnosis, preferring lipase, which is more specific, rises faster, and stays elevated longer, giving a wider diagnostic window.

Guiding treatment

Co-ordering both amylase and lipase is now flagged as a low-value, cost-adding practice in "Choosing Wisely"-type literature; lipase alone is sufficient for initial diagnosis and should not be repeated serially to monitor disease severity.

Clinical significance

Largely replaced by lipase in current pancreatitis diagnostic guidelines due to lower specificity.

References
  1. AAFP. (2017). Don't test for amylase in cases of suspected acute pancreatitis. Instead, test for lipase.
  2. Cleveland Clinic Journal of Medicine. (2017). Measuring both serum amylase and lipase for acute pancreatitis lowers quality and raises cost.